Previous studies have demonstrated a strong correlation between a high immune/stromal/ESTIMATE score and a poor prognosis [48] and the advancement of tumor grade in LGG, which suggests that ITGB1 also contributes to the progression of cancer by boosting stromal and immune cell infiltration in LGG. The gene discussed is ITGB1; the disease is cancer.